Characterizing the FDA’s Approach to Benefit-Risk Assessment throughout the Medical Product Life Cycle
Nicholas R. Harrison and Sarah Sheehan
Christina Silcox, Isha Sharma, & Arti Rai.
Leveraging Clinical Pharmacology to Optimize Drug Development for Nonalcoholic Steatohepatitis (NASH) and Cholestatic Liver Diseases
Nicholas R. Harrison & Sarah Sheehan
Nicholas R. Harrison, Philip T. Sager, Mitchell W. Krucoff, Michael A. Weber, & William B. White